Cajuput Oil: Uses, Side Effects, Dosage - Drugvu

ℹ️ Compiled from public regulatory records · Last regulator revision: July 11, 2025🚩 Report this page

Cajuput Oil

Active ingredient

Sold as Cajuputum · Throat Care · MENTHOL AND WINTERGREEN…

US FDAGB MHRA

Drug class: -
Availability: Over-the-counter
Routes: Oral
Markets covered: 2
Products on record: 4

Overview

Cajuput Oil is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
US United States	FDA	3	April 16, 2024
GB United Kingdom	MHRA	1	July 11, 2025

USUnited States· FDA

3 products

Uses

USOfficial regulatory label· revised January 24, 2024[1]

INDICATIONS AND USAGE SECTION
Formulated for associated symptoms such as dryness, irritation, inflammation, pain and hoarseness.

How to take

GBUnited Kingdom· MHRA

1 product

Uses

GBOfficial regulatory label· revised July 11, 2025[2]

For the symptomatic relief of muscular pain, rheumatic pain, fibrositis, sciatica, strains, lumbago, colds.

How to take

Sources & citations

[1]FDA DailyMed · 0fb69003-c66c-97… · revised January 24, 2024 [PDF]
[2]MHRA (UK) · PL031050110 · revised July 11, 2025

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.

Side effects & warnings

GBOfficial regulatory label· Adverse reactions· revised July 11, 2025[2]

The following undesirable effects have been reported in post-marketing experience for the active substances in this product. The frequency of undesirable effects considered at least possibly related to treatment is unknown (cannot be estimated from available data).
Immune system disorders Hypersensitivity reactions including: asthma, rhinitis and contact dermatitis. It is possible that skin burns, blisters and temporary skin reactions such as redness, burning sensation and rashes may occur. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

GBOfficial regulatory label· Warnings and precautions· revised July 11, 2025[2]

For external use only. Keep out of the sight and reach of children. 8). 5). Do not use if you are allergic to any of the ingredients or painkillers such as aspirin, ibuprofen and other NSAIDs. Consult your doctor before use if you are pregnant, breast-feeding, asthmatic or on any prescribed medicines.
For external use and only on unbroken skin. Avoid contact with the eyes and sensitive areas of skin. If symptoms persist or worsen after 2 weeks, a physician should be consulted. Eye contact with unwashed hands after application may potentially cause irritation.
Do not apply to broken skin or mucous membranes. . 6). 3). 5). Instruct patients not to smoke or go near naked flames - risk of severe burns. ) that has been in contact with this product burns more easily and is a serious fire hazard. ” Always try on a small area first.
Some people may experience discomfort particularly those with sensitive skin or if used in hot weather or after a bath. Not for use with occlusive dressings. Wash hands immediately after use. Discontinue use if excessive irritation or other unwanted effects occur.

This is not medical advice. Consult a qualified healthcare professional.